Mind Medicine (MindMed) Inc MMEDF:OTCQB

RT Quote | Exchange | USD
Last | 02/26/21 EST
3.32UNCH (UNCH)
Volume
2,100
52 week range
0.08 - 5.07

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.32
  • 52 Week High5.07
  • 52 Week High Date12/14/20
  • 52 Week Low0.08
  • 52 Week Low Date03/06/20
  • Market Cap1,053.05M
  • Shares Out315.91M
  • 10 Day Average Volume4.21M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change6,540

RATIOS/PROFITABILITY

  • EPS (TTM)-0.17
  • P/E (TTM)-19.03
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Mind Medicine (MindMed) Inc News

There is no recent news for this security.

Latest MMEDF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Mind Medicine (MindMed) Inc., formerly Broadway Gold Mining Ltd., is a neuro-pharmaceutical company. The Company discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The Company addresses the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.
Perry Dellelce
Chairman
Jamon Rahn
Chief Executive Officer
Miriam Wernli
President
Carol Nast
Chief Operating Officer
Paul Van Damme
Chief Financial Officer
Address
1166 Alberni Street, Suite 1604
Vancouver, BC
V6E 3Z3
Canada